Epilobii herba
Table of contents
Overview
This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of willow herb. The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing willow herb.
This summary is not intended to provide practical advice on how to use medicines containing willow herb. For practical information about using willow herb medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Key facts
Latin name | Epilobii herba |
English common name | Willow herb |
Botanical name | Epilobium angustifolium L. and/or Epilobium parviflorum Schreb. |
Therapeutic area |
Urinary tract and genital disorders
|
Status |
F: Assessment finalised
|
Date added to the inventory |
28/01/2014
|
Date added to priority list |
28/01/2014
|
Outcome of European assessment |
European Union herbal monograph
|
Documents
-
List item
European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba (PDF/126.76 KB)
Draft: consultation closed
First published: 09/04/2015
Last updated: 09/04/2015
Consultation dates: 09/04/2015 to 15/07/2015
EMA/HMPC/712511/2014 -
List item
Draft assessment report on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba (PDF/400.15 KB)
Draft
First published: 09/04/2015
Last updated: 09/04/2015
EMA/HMPC/712510/2014 -
List item
Draft list of references supporting the assessment of Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba (PDF/149.25 KB)
Draft
First published: 09/04/2015
Last updated: 09/04/2015
EMA/HMPC/712512/2014 -
List item
Call for scientific data for use in HMPC assessment work on Epilobii herba (PDF/78.1 KB)
Draft: consultation closed
First published: 17/02/2014
Last updated: 17/02/2014
Consultation dates: 15/02/2014 to 15/05/2014
EMA/HMPC/87611/2014